Saliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particles.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsDarpel, Karin E
Langner, Kathrin F A
Anthony, Simon J
Mellor, Philip S
Mertens, Peter P C
MetadataShow full item record
AbstractBluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) are related orbiviruses, transmitted between their ruminant hosts primarily by certain haematophagous midge vectors (Culicoides spp.). The larger of the BTV outer-capsid proteins, 'VP2', can be cleaved by proteases (including trypsin or chymotrypsin), forming infectious subviral particles (ISVP) which have enhanced infectivity for adult Culicoides, or KC cells (a cell-line derived from C. sonorensis). We demonstrate that VP2 present on purified virus particles from 3 different BTV strains can also be cleaved by treatment with saliva from adult Culicoides. The saliva proteins from C. sonorensis (a competent BTV vector), cleaved BTV-VP2 more efficiently than those from C. nubeculosus (a less competent/non-vector species). Electrophoresis and mass spectrometry identified a trypsin-like protease in C. sonorensis saliva, which was significantly reduced or absent from C. nubeculosus saliva. Incubating purified BTV-1 with C. sonorensis saliva proteins also increased their infectivity for KC cells ∼10 fold, while infectivity for BHK cells was reduced by 2-6 fold. Treatment of an 'eastern' strain of EHDV-2 with saliva proteins of either C. sonorensis or C. nubeculosus cleaved VP2, but a 'western' strain of EHDV-2 remained unmodified. These results indicate that temperature, strain of virus and protein composition of Culicoides saliva (particularly its protease content which is dependent upon vector species), can all play a significant role in the efficiency of VP2 cleavage, influencing virus infectivity. Saliva of several other arthropod species has previously been shown to increase transmission, infectivity and virulence of certain arboviruses, by modulating and/or suppressing the mammalian immune response. The findings presented here, however, demonstrate a novel mechanism by which proteases in Culicoides saliva can also directly modify the orbivirus particle structure, leading to increased infectivity specifically for Culicoides cells and, in turn, efficiency of transmission to the insect vector.
CitationSaliva proteins of vector Culicoides modify structure and infectivity of bluetongue virus particles. 2011, 6 (3):e17545 PLoS ONE
AffiliationPirbright Laboratory, Vector-borne Disease Programme, Institute for Animal Health, Woking, United Kingdom. email@example.com
The following license files are associated with this item:
- Enhanced infectivity of modified bluetongue virus particles for two insect cell lines and for two Culicoides vector species.
- Authors: Mertens PP, Burroughs JN, Walton A, Wellby MP, Fu H, O'Hara RS, Brookes SM, Mellor PS
- Issue date: 1996 Mar 15
- Occurrence of genetic drift and founder effect during quasispecies evolution of the VP2 and NS3/NS3A genes of bluetongue virus upon passage between sheep, cattle, and Culicoides sonorensis.
- Authors: Bonneau KR, Mullens BA, MacLachlan NJ
- Issue date: 2001 Sep
- Measurement of the infection and dissemination of bluetongue virus in culicoides biting midges using a semi-quantitative rt-PCR assay and isolation of infectious virus.
- Authors: Veronesi E, Antony F, Gubbins S, Golding N, Blackwell A, Mertens PP, Brownlie J, Darpel KE, Mellor PS, Carpenter S
- Issue date: 2013
- The Culicoides sonorensis inhibitor of apoptosis 1 protein protects mammalian cells from apoptosis induced by infection with African horse sickness virus and bluetongue virus.
- Authors: Vermaak E, Maree FF, Theron J
- Issue date: 2017 Mar 15
- The genome of the biting midge Culicoides sonorensis and gene expression analyses of vector competence for bluetongue virus.
- Authors: Morales-Hojas R, Hinsley M, Armean IM, Silk R, Harrup LE, Gonzalez-Uriarte A, Veronesi E, Campbell L, Nayduch D, Saski C, Tabachnick WJ, Kersey P, Carpenter S, Fife M
- Issue date: 2018 Aug 22